Yesterday, Bristol-Myers Squibb announced a recall of the blood thinner Coumadin. The reason for the Coumadin recall is that one production lot was found to have too high of a potency, which could in effect cause a blood thinner overdose. Clearly, this is a very serious issue and this recall is quite frightening. As a Pembroke Pines Products Liability Lawyer, I know many people who take this medication and some of my readers might as well. Thus, I felt that it was important to alert as many people as possible about this issue.
According to the FDA Coumadin Recall Release, “Patients who may have 5 mg tablets should not interrupt their therapy but should seek advice from their pharmacist to see if they have tablets originating from the affected lot.” As of yet, there reportedly haven’t been any instances of harm from the Coumadin recall and hopefully that remains true. As a Pembroke Pines Personal Injury Lawyer, what scares me the most about this recall is that the high potency of the recalled Coumadin could create an increased risk of bleeding. This is clearly not the intended effect of the drug, which is why it could cause serious harm.
We trust our medication to function properly and to help us, but it is cases like this one that remind us of the potential harm that they can cause if they are defective. Hypothetically speaking, from a Pembroke Pines Personal Injury Lawyer’s perspective, it can be said that drug manufacturers have a duty to only sell medication that is beneficial for our health. In the case of a recall of a defective drug, if proven to be a dangerous drug, the manufacturer has breached that aforementioned duty. One can only hope that no injuries result from this potentially dangerous scenario and that all users of Coumadin check with their pharmacist as recommended by Brystol-Myers Squibb and the FDA.